Literature DB >> 221766

Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats.

J J Wurtman, R J Wurtman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221766     DOI: 10.1016/0024-3205(79)90339-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  19 in total

1.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

2.  A role for S6 kinase and serotonin in postmating dietary switch and balance of nutrients in D. melanogaster.

Authors:  Misha A Vargas; Ningguang Luo; Atsushi Yamaguchi; Pankaj Kapahi
Journal:  Curr Biol       Date:  2010-05-13       Impact factor: 10.834

Review 3.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Effects of precursors on brain neurotransmitter synthesis and brain functions.

Authors:  J D Fernstrom
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

5.  The composition of lunch determines afternoon plasma tryptophan ratios in humans.

Authors:  H R Lieberman; B Caballero; N Finer
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 6.  Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.

Authors:  F Brambilla
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  5-HT manipulation and dietary choice: variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions.

Authors:  C L Lawton; J E Blundell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  The anorectic effect of increasing doses of L-tryptophan in obese patients.

Authors:  H Cavaliere; G Medeiros-Neto
Journal:  Eat Weight Disord       Date:  1997-12       Impact factor: 4.652

9.  The treatment of obesity by carbohydrate deprivation suppresses plasma tryptophan and its ratio to other large neutral amino acids.

Authors:  E Heraief; P Burckhardt; C Mauron; J J Wurtman; R J Wurtman
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 10.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.